Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and HbS Disease

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with HbS Disease in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's6 (85.71)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
An, X; Anstee, D; Chasis, JA; Kaul, DK; Liu, XD; Mankelow, T; Mohandas, N; Parsons, S; Spring, F; Zhang, X1
Barabino, GA; Chang, HY; Finnegan, EM; Jonczyk, A; Kaul, DK; Liu, XD1
Ibe, BO; Johnson, C; Kurantsin-Mills, J; Oh, SO; Raj, JU1
Coller, BS; Kaul, DK; Liu, XD; Nagel, RL; Nakada, MT; Tsai, HM1
Kaul, DK; Liu, X; Nagel, RL1
Haynes, J; Obiako, B1
Brugnara, C; Jarolim, P; Rivera, A1

Other Studies

7 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and HbS Disease

ArticleYear
Peptides based on alphaV-binding domains of erythrocyte ICAM-4 inhibit sickle red cell-endothelial interactions and vaso-occlusion in the microcirculation.
    American journal of physiology. Cell physiology, 2006, Volume: 291, Issue:5

    Topics: Anemia, Sickle Cell; Animals; Cell Adhesion; Cell Adhesion Molecules; Endothelial Cells; Erythrocytes, Abnormal; Humans; In Vitro Techniques; Integrin alphaV; Microcirculation; Peptides; Platelet Activating Factor; Protein Binding; Protein Structure, Tertiary; Protein Transport; Rats; Regression Analysis

2006
Small-molecule cyclic alpha V beta 3 antagonists inhibit sickle red cell adhesion to vascular endothelium and vasoocclusion.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:2

    Topics: Anemia, Sickle Cell; Animals; Cell Adhesion; Cells, Cultured; Endothelial Cells; Erythrocytes; Humans; Integrin alphaVbeta3; Microcirculation; Peptides, Cyclic; Platelet Activating Factor; Rats; Splanchnic Circulation; Vascular Patency; Vascular Resistance

2007
Platelet-activating factor in plasma of patients with sickle cell disease in steady state.
    The Journal of laboratory and clinical medicine, 1997, Volume: 130, Issue:2

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adolescent; Adult; Aging; Anemia, Sickle Cell; Blood Platelets; Body Weight; Female; Hemoglobins; Humans; Male; Phospholipases A; Platelet Activating Factor; Platelet Count

1997
Monoclonal antibodies to alphaVbeta3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor.
    Blood, 2000, Jan-15, Volume: 95, Issue:2

    Topics: Abciximab; Adult; Anemia, Sickle Cell; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cecum; Cell Adhesion; Endothelium, Vascular; Erythrocytes; Humans; Immunoglobulin Fab Fragments; Platelet Activating Factor; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Receptors, Vitronectin; Reference Values; Venules

2000
Ameliorating effects of fluorocarbon emulsion on sickle red blood cell-induced obstruction in an ex vivo vasculature.
    Blood, 2001, Nov-15, Volume: 98, Issue:10

    Topics: Adult; Anemia, Sickle Cell; Animals; Cecum; Cell Adhesion; Drug Carriers; Drug Evaluation, Preclinical; Emulsions; Endothelium, Vascular; Erythrocytes, Abnormal; Fluorocarbons; Humans; Hydrocarbons, Brominated; Microcirculation; Oxygen; Perfusion; Platelet Activating Factor; Rats; Solubility; Vascular Resistance

2001
Activated polymorphonuclear cells increase sickle red blood cell retention in lung: role of phospholipids.
    American journal of physiology. Heart and circulatory physiology, 2002, Volume: 282, Issue:1

    Topics: Anemia, Sickle Cell; Animals; Cell Adhesion; Chromium Radioisotopes; Erythrocytes; Humans; In Vitro Techniques; Leukotriene B4; Male; NADPH Oxidases; Neutrophils; Perfusion; Phospholipids; Platelet Activating Factor; Positive-Pressure Respiration; Rats; Rats, Sprague-Dawley; Tetradecanoylphorbol Acetate; Tidal Volume

2002
Modulation of Gardos channel activity by cytokines in sickle erythrocytes.
    Blood, 2002, Jan-01, Volume: 99, Issue:1

    Topics: Anemia, Sickle Cell; Calcium; Cell Size; Chemokine CCL5; Cytokines; Endothelin Receptor Antagonists; Endothelin-1; Erythrocyte Count; Erythrocytes, Abnormal; Humans; Interleukin-10; Kinetics; Oligopeptides; Piperidines; Platelet Activating Factor; Platelet Membrane Glycoproteins; Potassium Channels, Calcium-Activated; Protein Kinase C; Receptor, Endothelin B; Receptors, CCR5; Receptors, Cell Surface; Receptors, Chemokine; Receptors, Endothelin; Receptors, G-Protein-Coupled; Rubidium Radioisotopes

2002